GRTX
Price:
$0.092
Market Cap:
$6.98M
Galera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the creation and commercialization of therapies aimed at revolutionizing cancer radiotherapy. Its lead investigational drug, avasopasem manganese (GC4419), functions as a small molecule superoxide dismutase mimetic. This compound has successfully completed a Phase III clinical trial targeting severe oral mucositis induced by radiation therapy in head and neck cancer (HNC) patients. Furthermore, GC4419 is currently undergoing Phase IIa clinical trials for radiotherapy-induced esophagitis in lung cancer patients, as well as for HNC patients undergoing standard-of-care radiation treatment. The comp...[Read more]
Industry
Biotechnology
IPO Date
2019-11-07
Stock Exchange
OTC
Ticker
GRTX
According to Galera Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -210.64%. This represents a change of -136.52% compared to the average of 576.70% of the last 4 quarters.
The mean historical ROE of Galera Therapeutics, Inc. over the last ten years is 143.90%. The current -210.64% ROE has changed -246.38% with respect to the historical average. Over the past ten years (40 quarters), GRTX's ROE was at its highest in in the December 2025 quarter at 2.34%. The ROE was at its lowest in in the December 2020 quarter at -327.97%.
Average
143.90%
Median
30.94%
Minimum
-1213.11%
Maximum
2.28%
Discovering the peaks and valleys of Galera Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 17.14%
Maximum Annual ROE = 2.28%
Minimum Annual Increase = -430.29%
Minimum Annual ROE = -1213.11%
| Year | ROE | Change |
|---|---|---|
| 2025 | 2.28% | 17.14% |
| 2024 | 13.19% | -70.70% |
| 2023 | 45.04% | -20.97% |
| 2022 | 56.99% | -58.95% |
| 2021 | 138.84% | -111.45% |
| 2020 | -1213.11% | 1.53% |
| 2019 | -74.60% | -430.29% |
| 2018 | 22.59% | -26.99% |
The current ROE of Galera Therapeutics, Inc. (GRTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
777.81%
5-year avg
505.85%
10-year avg
143.90%
Galera Therapeutics, Inc.’s ROE is less than Health Sciences Group, Inc. (2.53%), greater than Medigene AG (-55.69%), less than Agentix Corp. (17.76%), less than Stemcell Holdings, Inc. (93.24%), less than Neon Bloom, Inc. (13.99%), less than Vaccinex, Inc. (776.58%), less than Aion Therapeutic Inc. (190.59%), less than Ember Therapeutics, Inc. (10.25%), greater than Hemp, Inc (-38.72%), less than Assure Holdings Corp. (528.43%),
| Company | ROE | Market cap |
|---|---|---|
| 2.53% | $1.87M | |
| -55.69% | $38.17M | |
| 17.76% | $841.41K | |
| 93.24% | $1.64M | |
| 13.99% | $1.27M | |
| 776.58% | $2.70M | |
| 190.59% | $2.07M | |
| 10.25% | $398.00 | |
| -38.72% | $882.95K | |
| 528.43% | $1.57K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Galera Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Galera Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Galera Therapeutics, Inc.'s ROE?
How is the ROE calculated for Galera Therapeutics, Inc. (GRTX)?
What is the highest ROE for Galera Therapeutics, Inc. (GRTX)?
What is the 3-year average ROE for Galera Therapeutics, Inc. (GRTX)?
What is the 5-year average ROE for Galera Therapeutics, Inc. (GRTX)?
How does the current ROE for Galera Therapeutics, Inc. (GRTX) compare to its historical average?